Testing effectiveness (Phase 2)Study completedNCT01303380What this trial is testingCanakinumab in Patients With Active Hyper-IgD SyndromeWho this might be right forMevalonate Kinase Deficiency Novartis Pharmaceuticals 9
Not applicableStudy completedNCT04330053What this trial is testingDocumentation of Fall Incidents and Application of a Fall Prevention Programme for Seniors in Northern GreeceWho this might be right forElderlyAccidental FallsPrevention+1 more Aristotle University Of Thessaloniki 150
Not applicableNot Yet RecruitingNCT05292768What this trial is testingAre Mast Cells Involved in Autoinflammatory DiseasesWho this might be right forAutoinflammatory DiseaseFMFTRAPS+3 more Assistance Publique - Hôpitaux de Paris 590
Not applicableWithdrawnNCT01568736What this trial is testingB7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase DeficiencyWho this might be right forHyper IgD SyndromeMevalonate Kinase Deficiency Michigan Technological University
Not applicableStudy completedNCT01542424What this trial is testingAn Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes MellitusWho this might be right forDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2 Novo Nordisk A/S 1,889
Not applicableEnded earlyNCT00260299What this trial is testingDietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase DeficiencyWho this might be right forMevalonic AciduriaMevalonate Kinase DeficiencyImmune System Diseases+2 more Oregon Health and Science University 1
Not applicableStudy completedNCT05468632What this trial is testingA Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)Who this might be right forDiabetes Mellitus, Type 2 Novo Nordisk A/S 314
Not applicableStudy completedNCT00665093What this trial is testingObservational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2 Novo Nordisk A/S 1,569
Large-scale testing (Phase 3)Study completedNCT02334748What this trial is testingCanakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 StudiesWho this might be right forSystemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT02911857What this trial is testingAn Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever SyndromesWho this might be right forPeriodic Fevers Syndrome Novartis Pharmaceuticals 4
Not applicableLooking for participantsNCT06838143What this trial is testingIlaris NIS in KoreaWho this might be right forHereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more Novartis Pharmaceuticals 25
Not applicableStudy completedNCT00842894What this trial is testingSafety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in MacedoniaWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 3,421
Not applicableLooking for participantsNCT06497829What this trial is testingGeranylgeraniol Supplementation in Patients With Mevalonate Kinase DeficiencyWho this might be right forMevalonate Kinase Deficiency University Hospital, Motol 6